State Street
DFTX

State Street’s Definium Therapeutics DFTX Stock Holding History

State Street’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.7M Buy
2,471,873
+103,807
+4% +$1.76M ﹤0.01% 1777
2025
Q4 		$31.7M Buy
2,368,066
+443,173
+23% +$5.48M ﹤0.01% 2002
2025
Q3 		$22.7M Buy
1,924,893
+119,000
+7% +$1.11M ﹤0.01% 2166
2025
Q2 		$11.7M Sell
1,805,893
-36,321
-2% -$239K ﹤0.01% 2494
2025
Q1 		$10.8M Buy
1,842,214
+60,715
+3% +$435K ﹤0.01% 2484
2024
Q4 		$12.4M Sell
1,781,499
-33,330
-2% -$229K ﹤0.01% 2498
2024
Q3 		$10.3M Buy
1,814,829
+9,782
+0.5% +$68K ﹤0.01% 2587
2024
Q2 		$13M Buy
1,805,047
+1,686,143
+1,418% +$14.7M ﹤0.01% 2407
2024
Q1 		$1.12M Sell
118,904
-3,200
-3% -$18.2K ﹤0.01% 3442
2023
Q4 		$447K Buy
122,104
+104
+0.1% +$313 ﹤0.01% 3661
2023
Q3 		$382K Hold
122,000
– – ﹤0.01% 3731
2023
Q2 		$436K Hold
122,000
– – ﹤0.01% 3723
2023
Q1 		$387K Buy
122,000
+23,099
+23% +$76.8K ﹤0.01% 3835
2022
Q4 		$218K Buy
98,901
+44,994
+83% +$125K ﹤0.01% 4064
2022
Q3 		$189K Sell
53,907
-10,280
-16% -$98.7K ﹤0.01% 4168
2022
Q2 		$616K Sell
64,187
-345,513
-84% -$4.37M ﹤0.01% 3757
2022
Q1 		$6.82M Buy
409,700
+27,784
+7% +$482K ﹤0.01% 3028
2021
Q4 		$7.91M Buy
381,916
+6,310
+2% +$201K ﹤0.01% 3031
2021
Q3 		$13.1M Buy
375,606
+77,275
+26% +$3.34M ﹤0.01% 2721
2021
Q2 		$15.4M Buy
+298,331
New +$15.7M ﹤0.01% 2653

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM

State Street's DFTX Position: Q1 2026 in Review

State Street increased its Definium Therapeutics (DFTX) stake by 4.4% in Q1 2026, buying an estimated $1.76M and bringing the position to 2,471,873 shares worth $46.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

State Street first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • State Street held 2,471,873 shares of Definium Therapeutics worth $46.7M as of Q1 2026.
  • State Street bought 103,807 Definium Therapeutics shares in Q1 2026, an estimated $1.76M.
  • Definium Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1777 holding.
  • State Street first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.